AGL 40.00 No Change ▼ 0.00 (0%)
AIRLINK 127.25 Increased By ▲ 0.21 (0.17%)
BOP 6.60 Decreased By ▼ -0.07 (-1.05%)
CNERGY 4.50 Decreased By ▼ -0.01 (-0.22%)
DCL 8.57 Increased By ▲ 0.02 (0.23%)
DFML 41.75 Increased By ▲ 0.31 (0.75%)
DGKC 87.50 Increased By ▲ 0.65 (0.75%)
FCCL 32.40 Increased By ▲ 0.12 (0.37%)
FFBL 64.99 Increased By ▲ 0.19 (0.29%)
FFL 10.30 Increased By ▲ 0.05 (0.49%)
HUBC 109.51 Decreased By ▼ -0.06 (-0.05%)
HUMNL 14.75 Increased By ▲ 0.07 (0.48%)
KEL 5.08 Increased By ▲ 0.03 (0.59%)
KOSM 7.56 Increased By ▲ 0.10 (1.34%)
MLCF 41.50 Increased By ▲ 0.12 (0.29%)
NBP 59.50 Decreased By ▼ -0.91 (-1.51%)
OGDC 192.35 Increased By ▲ 2.25 (1.18%)
PAEL 28.11 Increased By ▲ 0.28 (1.01%)
PIBTL 7.84 Increased By ▲ 0.01 (0.13%)
PPL 151.21 Increased By ▲ 1.15 (0.77%)
PRL 26.49 Decreased By ▼ -0.39 (-1.45%)
PTC 16.15 Increased By ▲ 0.08 (0.5%)
SEARL 83.48 Decreased By ▼ -2.52 (-2.93%)
TELE 7.77 Increased By ▲ 0.06 (0.78%)
TOMCL 35.42 Increased By ▲ 0.01 (0.03%)
TPLP 8.12 No Change ▼ 0.00 (0%)
TREET 16.05 Decreased By ▼ -0.36 (-2.19%)
TRG 53.15 Decreased By ▼ -0.14 (-0.26%)
UNITY 26.67 Increased By ▲ 0.51 (1.95%)
WTL 1.27 Increased By ▲ 0.01 (0.79%)
BR100 9,985 Increased By 101.4 (1.03%)
BR30 31,147 Increased By 547.3 (1.79%)
KSE100 94,178 Increased By 822.4 (0.88%)
KSE30 29,173 Increased By 242.5 (0.84%)

US regulators gave tentative approval Wednesday to a deal allowing Pfizer to buy pharmaceutical Wyeth, boosting the size of the world's biggest drugmaker. The Federal Trade Commission said it would approve the 68-billion-dollar deal but require "significant divestitures to preserve competition in multiple US markets for animal pharmaceuticals and vaccines."
The Commission voted 2-0 to approve the plan. The order will be subject to public comment for 30 days, until November 16, after which the FTC will decide whether to make it final. An FTC statement that a "thorough investigation" concluded that "the transaction does not raise anticompetitive concerns in any human health product markets." "The Commission is dedicated to promoting competition in health care
markets to ensure that costs are contained and to protect incentives for pharmaceutical companies to develop new medications," the statement added. Pfizer, already the world's biggest pharmaceutical firm, announced the planned merger in January, seeking diversification as it prepares for the expiration of patents on its blockbuster drugs.

Copyright Agence France-Presse, 2009

Comments

Comments are closed.